Predict your next investment

Venture Capital
pbmcap.com

See what CB Insights has to offer

Investments

27

Portfolio Exits

10

About PBM Capital Group

PBM Capital Group is a private investment firm primarily focused on healthcare investments. The PBM Capital Group partners with exceptional scientists, engineers and entrepreneurs who have developed game-changing technology that can improve and save the lives of millions of people. The goal is to create financially strong companies that change the way we live our lives through science, innovation, and creativity. PBM creates value by applying extensive industry knowledge and contacts, providing superior operational expertise and bringing entrepreneurial spirit to attractive investment opportunities.

PBM Capital Group Headquarter Location

200 Garrett Street Suite P

Charlottesville, Virginia, 22902,

United States

434-980-8100

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing PBM Capital Group

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find PBM Capital Group in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest PBM Capital Group News

Liquidia to acquire RareGen in all-stock deal

Jun 29, 2020

Jun. 29, 2020 4:19 PM ET Liquidia Technologies (NASDAQ: LQDA ) has agreed to acquire privately held RareGen, LLC , a portfolio company of PBM Capital Group, in a all-stock transaction. The Durham, NC-based pharma firm recently launched a generic version of treprostinil, in partnership with Novartis (NYSE: NVS ) unit Sandoz, for the treatment of pulmonary arterial hypertension. Concurrently, LQDA has launched a public offering of common stock. Price, volume and terms have yet be be announced.

PBM Capital Group Investments

27 Investments

PBM Capital Group has made 27 investments. Their latest investment was in Saliogen Therapeutics as part of their Series B on December 12, 2021.

CBI Logo

PBM Capital Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/7/2021

Series B

Saliogen Therapeutics

$115M

No

3

9/9/2021

Series B

LEXEO Therapeutics

$100M

No

9

8/24/2021

Series C

Xalud Therapeutics

$30M

No

11

2/18/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

2/9/2021

Growth Equity

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/7/2021

9/9/2021

8/24/2021

2/18/2021

2/9/2021

Round

Series B

Series B

Series C

Series A

Growth Equity

Company

Saliogen Therapeutics

LEXEO Therapeutics

Xalud Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$115M

$100M

$30M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

9

11

10

10

PBM Capital Group Portfolio Exits

10 Portfolio Exits

PBM Capital Group has 10 portfolio exits. Their latest portfolio exit was Nanoview Biosciences on May 04, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/4/2022

Acquired

$99M

1

7/27/2021

IPO

$99M

Public

9

2/4/2021

IPO

$99M

Public

23

9/24/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

6/22/2020

Acquired - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/4/2022

7/27/2021

2/4/2021

9/24/2020

6/22/2020

Exit

Acquired

IPO

IPO

IPO

Acquired - II

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Subscribe to see more

Subscribe to see more

Sources

1

9

23

10

10

PBM Capital Group Acquisitions

2 Acquisitions

PBM Capital Group acquired 2 companies. Their latest acquisition was AkaRx on May 17, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/17/2016

Series A

$99M

$12.5M

Acq - Fin

1

2/5/2014

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/17/2016

2/5/2014

Investment Stage

Series A

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$12.5M

Note

Acq - Fin

Subscribe to see more

Sources

1

10

PBM Capital Group Team

6 Team Members

PBM Capital Group has 6 team members, including current Founder, Chief Executive Officer, Paul Manning.

Name

Work History

Title

Status

Paul Manning

Founder, Chief Executive Officer

Current

Sean Stalfort

Benevolent Capital

President

Current

Kevin Combs

Executive Vice President

Current

Jayson Rieger

Senior Vice President

Current

Damian deGoa

Managing Director

Current

Name

Paul Manning

Sean Stalfort

Kevin Combs

Jayson Rieger

Damian deGoa

Work History

Benevolent Capital

Title

Founder, Chief Executive Officer

President

Executive Vice President

Senior Vice President

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.